NGVT Reports Losses in Q4, Missing Estimates, Revenues Dip Y/Y

Ingevity Corporation NGVT recorded a fourth-quarter 2025 loss of $84.6 million, or a loss of $2.37 per share. This compared unfavorably with an income of $16.6 million or 46 cents per share in the year-ago quarter.

Excluding one-time items, adjusted earnings (from continuing operations) in the quarter were 58 cents per share, down from 95 cents a year ago. The figure missed the Zacks Consensus Estimate of 74 cents per share.

Revenues from continuing operations fell 3% year over year to $255.1 million in the quarter. This decline was due to lower sales in Advanced Polymer Technologies and Performance Materials.

Ingevity Corporation Price, Consensus and EPS Surprise

Ingevity Corporation price-consensus-eps-surprise-chart | Ingevity Corporation Quote

NGVT’s Segmental Review

The Performance Chemicals division generated revenues of $67.4 million in the reported quarter, up around 6.5% year over year. Industrial Specialties’ product line was excluded. Road Technologies saw a volume growth, driven by an extended paving season. Earnings before interest, taxes, depreciation and amortization (EBITDA) for the segment declined to a negative $1.2 million as a result of competitive pricing pressure in Road Markings.

Revenues in the Performance Materials unit fell around 3% year over year to $151.2 million. This was a result of lower sales in North America from supply chain disruptions in the auto industry. Segment EBITDA was $78 million, down 4.5% year over year, impacted by lower global auto production driven by tariff uncertainty and supply chain challenges.

Sales in the Advanced Polymer Technologies segment were down 17% to $36.5 million due to dampened demand. Segment EBITDA was $5.5 million, down 21% due to lower volumes.

NGVT’s Financials

The fourth-quarter operating cash flow was $97.1 million, with free cash flow of $73.5 million. There were share repurchases of $31 million during the quarter, leaving $297 million remaining under the current share repurchase authorization. Net leverage improved to 2.6x from the previous quarter’s 2.7x.

NGVT’s 2026 Outlook

NGVT expects full-year 2026 sales between $1.1 billion and $1.2 billion. Adjusted EBITDA guidance is between $380 million and $400 million, with adjusted EPS between $4.80 to $5.20. The company expects free cash flow between $225 million and $250 million in 2026.

NGVT Stock’s Price Performance

Shares of Ingevity have gained 46.1% in a year compared with the industry’s 7.1% rise.

Image Source: Zacks Investment Research

NGVT’s Rank & Key Picks

NGVT currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Orla Mining Ltd. ORLA, Sociedad Química y Minera de Chile S.A. SQM and Avino Silver & Gold Mines Ltd. ASM.

Orla Mining is scheduled to report fourth-quarter results on March 19. The Zacks Consensus Estimate for ORLA’s fourth-quarter earnings is pegged at 36 cents, indicating 414.29% year over year growth. ORLA currently flaunts a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. 

Sociedad is slated to report fourth-quarter results on Feb. 27. The Zacks Consensus Estimate for earnings is pegged at 75 cents per share, indicating 78.57% year over year growth. SQM sports a Zacks Rank #1 at present.

Avino Silver is slated to report fourth-quarter results on March 11. The consensus estimate for ASM’s earnings is pegged at 6 cents. ASM, presently carrying a Zacks Rank #2 (Buy), beat the consensus estimate in all the last four quarters, the average earnings surprise being 150%.

Just Released: Zacks Top 10 Stocks for 2026

Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.

From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.

Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research